COVID-19 and the long-term cardio-respiratory and metabolic health complications.


Journal

Reviews in cardiovascular medicine
ISSN: 1530-6550
Titre abrégé: Rev Cardiovasc Med
Pays: Singapore
ID NLM: 100960007

Informations de publication

Date de publication:
09 02 2022
Historique:
received: 15 12 2021
revised: 07 01 2022
accepted: 12 01 2022
entrez: 1 3 2022
pubmed: 2 3 2022
medline: 8 3 2022
Statut: ppublish

Résumé

Severe acute respiratory syndrome coronavirus type-2 (SARS-CoV-2) transmission continues to impact people globally. Whilst the acute symptoms and management strategies are well documented, millions of people globally are experiencing a prolonged and debilitating symptom profile that is reported to last months and even years. COVID-19 is a multi-system disease however the magnitude of the effects and its associated legacy is presently not well understood. Early reports indicate that multidisciplinary approaches between clinical and non-clinical entities are needed to provide effective and rehabilitative patient support pathways and restore pre-COVID-19 quality of life and functional status. Accordingly, this review provides a summary of the impact on cardiovascular, inflammatory, respiratory, and musculoskeletal function following an acute COVID-19 infection along with the prolonged effects of long-COVID.

Identifiants

pubmed: 35229544
pii: S1530-6550(22)00340-4
doi: 10.31083/j.rcm2302053
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

53

Informations de copyright

© 2022 The Author(s). Published by IMR Press.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest. Mark Faghy is serving as one of the Guest editors of this journal. We declare that Mark Faghy had no involvement in the peer review of this article and has no access to information regarding its peer review. Full responsibility for the editorial process for this article was delegated to Peter Kokkinos.

Auteurs

Ruth Ashton (R)

Human Sciences Research Centre, University of Derby, DE22 1GB Derby, UK.

Paul Ansdell (P)

Department of Sport, Exercise and Rehabilitation, Northumbria University, NE1 8ST Newcastle upon Tyne, UK.

Emily Hume (E)

Department of Sport, Exercise and Rehabilitation, Northumbria University, NE1 8ST Newcastle upon Tyne, UK.

Tom Maden-Wilkinson (T)

Advanced Well-being Research Centre, Sheffield Hallam University, S9 3TU Sheffield, UK.

Declan Ryan (D)

Centre for Physical Activity and Life Sciences, University of Northampton, NN1 5PH Northampton, UK.

Esme Tuttiett (E)

Department of Oncology and Metabolism, The Medical School, University of Sheffield, S19 2RX Sheffield, UK.

Mark Faghy (M)

Human Sciences Research Centre, University of Derby, DE22 1GB Derby, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH